Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Alkermes Plc
ALKSCurrent price
26.86 USD
-0.01 USD (-0.04%)
Last closed
26.86 USD
Company
www.alkermes.com
ISIN
USG017671052
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
4 684 804 608 USD
Yield for 12 month
-6.90 %
1Y
3Y
5Y
10Y
15Y
ALKS
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Address: Connaught House, Dublin, Ireland, D04 C5Y6
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
34.92 USDP/E ratio
12.4781Dividend Yield
–Current Year
+1 663 405 000 USD
Last Year
+1 111 795 000 USD
Current Quarter
+399 131 000 USD
Last Quarter
+350 372 000 USD
Current Year
+1 374 679 000 USD
Last Year
+893 687 000 USD
Current Quarter
+336 245 000 USD
Last Quarter
+289 269 000 USD
Key Figures ALKS
1 year
3 years
5 years
10 years
EBITDA
354 932 992 USD
Operating Margin TTM
PE Ratio
12.4781
Return On Assets TTM
8.62 %
PEG Ratio
-1057.29
Return On Equity TTM
30.08 %
Wall Street Target Price
34.92 USD
Revenue TTM
1 507 916 032 USD
Book Value
7.74 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-35.4 %
Dividend Yield
–
Gross Profit TTM
893 687 000 USD
Earnings per share
2.28 USD
Diluted Eps TTM
2.28 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-61.7 %
Profit Margin
19.15 %
Dividend Analytics ALKS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALKS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
15.05.2000
Dividend Date
–
Stock Valuation ALKS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
12.4781
Forward PE
12.0919
Enterprise Value Revenue
2.7698
Price Sales TTM
3.1068
Enterprise Value EBITDA
10.6941
Price Book MRQ
3.6486
Financials ALKS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALKS
For 52 weeks
22.01 USD
32.88 USD
50 Day MA
26.07 USD
Shares Short Prior Month
18 543 231
200 Day MA
26.31 USD
Short Ratio
8.41
Shares Short
17 697 146
Short Percent
15.9 %
BeatStart